Abstract
To our knowledge we are the first to utilize ligand-directed proximity accelerated bioconjugation
chemistry to deliver a therapeutic payload. Here we report a new chemical moiety based on
nitrophenol carbonates for ligand-directed in situ labeling of avidin with an
immunostimulant prodrug. This renders avidin a depot for time-dependent release
of bioavailable immunostimulant following hydrolysis and self-immolation of the
transient modification. Structural biology was utilized to verify the binding
pose of the modified biotin directing group and offer insight into nucleophilic
residues proximal to the nitrophenol carbonate. Time-dependent release of the
immunostimulant was monitored with an immune cell line to demonstrate the
release of bioavailable immunostimulant over 48 h. We show that this scaffold
warrants further investigation for the time-dependent delivery of therapeutics
and further investigation of protein ligand pairs beyond biotin and avidin used
for this work